Equity (Tables)

12 Months Ended

Dec. 31, 2021

Equity [Abstract]

Summarizes the Aggregate Number of Stock Options And Restricted Stock Unit

The following table summarizes the aggregate number of stock options and restricted stock units, or RSUs, outstanding under the 2020 Plan as of December 31, 2021:

	December 31, 2021
Outstanding stock options		18,493,303
% of outstanding shares on a fully diluted basis		4	%
Outstanding RSUs		9,277,176
% of outstanding shares on a fully diluted basis		2	%

Summary of Equity Awards Activity

The following table represents equity awards activity during the years ended December 31, 2021 and 2020:

	For the Year Ended December 31,
	2021		2020
Common shares issued for stock option exercises		1,203,845		1,623,460
Gross and net proceeds from stock option exercises	$	2,921,000	$	5,158,000
Common shares issued in settlement of vested RSUs		2,133,328		1,267,164
Shares retained for settlement of employee tax obligations ─ RSUs		782,917		461,143
Common shares issued in settlement of vested Performance-Based RSUs (1)		1,923,316		1,240,584
Shares retained for settlement of employee tax obligations ─ Performance-Based RSUs		816,931		514,784

(1)Performance-based RSUs vested in connection with the achievement of certain regulatory and sales performance conditions associated with the REDUCE-IT clinical trial and subsequent revenue growth. These performance-based RSUs have fully vested as of August 2021.